Sendero Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.27M Sell
1,958
-56
-3% -$66.1K 0.23% 76
2026
Q2
$2.42M Buy
2,014
+1,282
+175% +$1.31M 0.24% 71
2026
Q1
$673K Sell
732
-53
-7% -$53.7K 0.07% 139
2025
Q4
$843K Buy
+785
New +$751K 0.09% 121

Other funds holding LLY

Sendero Wealth Management's LLY Position: Q3 2026 in Review

Sendero Wealth Management reduced its Eli Lilly (LLY) stake by 2.8% in Q3 2026, selling an estimated $66.1K and leaving 1,958 shares worth $2.27M. The position accounts for 0.23% of the portfolio, ranked #76.

Sendero Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.42M in Q2 2026. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Sendero Wealth Management held 1,958 shares of Eli Lilly worth $2.27M as of Q3 2026.
  • Sendero Wealth Management sold 56 Eli Lilly shares in Q3 2026, an estimated $66.1K.
  • Eli Lilly made up 0.23% of Sendero Wealth Management's portfolio in Q3 2026, its #76 holding.
  • Sendero Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Sendero Wealth Management's Eli Lilly position peaked at $2.42M in Q2 2026.
  • 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Sendero Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.